866-997-4948(US-Canada Toll Free)

Endometrial Cancer Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 475 Pages

Endometrial Cancer Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Endometrial Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Endometrial Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Endometrial Cancer to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Endometrial Cancer Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Endometrial Cancer 34
Jun 26, 2017: Xenetic Biosciences Commences Patient Enrollment in Phase 2 Study Evaluating XBIO-101 in Conjunction with Progestin Therapy for the Treatment of Endometrial Cancer 34
Jun 13, 2017: PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers 34
May 18, 2017: PharmaMar Announces new data on Lurbinectedin during ASCO 2017 35
May 18, 2017: Eisai to Present Abstracts on Lenvatinib At 53rd ASCO Annual Meeting 35
Clinical Trial Profile Snapshots 36
Appendix 473
Abbreviations 473
Definitions 473
Research Methodology 474
Secondary Research 474
About GlobalData 475
Contact Us 475
Disclaimer 475
Source 475

List of Tables
Endometrial Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
Endometrial Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Endometrial Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Endometrial Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Endometrial Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Endometrial Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Endometrial Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15
Endometrial Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 16
Proportion of Endometrial Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 17
Endometrial Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Endometrial Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Endometrial Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Endometrial Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Endometrial Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Endometrial Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 23
Endometrial Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
Endometrial Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Endometrial Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Endometrial Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Endometrial Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Endometrial Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Endometrial Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures
Endometrial Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Endometrial Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Endometrial Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Endometrial Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Endometrial Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Endometrial Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Endometrial Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 15
Endometrial Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 16
Proportion of Endometrial Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 17
Endometrial Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Endometrial Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Endometrial Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 20
Endometrial Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Endometrial Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Endometrial Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
Endometrial Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
Endometrial Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Endometrial Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Endometrial Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
Endometrial Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Endometrial Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Endometrial Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
GlobalData Methodology 474

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *